K210983

Substantially Equivalent

BD Epilor Syringe

Applicant: Becton, Dickinson and Company
Product code: CAZ
Advisory panel: Anesthesiology
Date received: 2021-04-01
Decision date: 2022-05-19
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Franklin Lakes, NJ, US

Adverse events under product code CAZ

product code CAZ

Injury: 145
Malfunction: 942
Other: 1
Total: 1,088

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.